Key facts
- This page summarizes Eugene Frederick Leffler III's Form 4 filing for Biofrontera Inc. (BFRI).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 16 Jul 2024, 19:52.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Additional SEC filing notes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of BFRI common stock. The reporting person received the restricted stock units as an award for no consideration.
Footnote F2
The restricted stock units vest over one year in two equal installments, the first of which will be on the six month anniversary of the grant date and the second of which will be on the one-year anniversary of the grant date. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
Footnote F3
The option vests in three virtually equal annual installments beginning on July 12, 2025.
SEC remarks
All share amounts have been adjusted for the reverse stock split that occurred on June 28, 2023.